Total Payments
$21,241
2024 Payments
$1,834
Companies
34
Transactions
242
Medicare Patients
3,576
Medicare Billing
$477,470
Payment Breakdown by Category
Other$14,800 (69.7%)
Food & Beverage$6,186 (29.1%)
Travel$184.35 (0.9%)
Education$71.24 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $14,800 | 1 | 69.7% |
| Food and Beverage | $6,186 | 239 | 29.1% |
| Travel and Lodging | $184.35 | 1 | 0.9% |
| Education | $71.24 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $15,531 | 13 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $729.81 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $577.80 | 45 | $0 (2024) |
| Edwards Lifesciences Corporation | $549.63 | 8 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $483.37 | 11 | $0 (2024) |
| Inari Medical, Inc. | $335.98 | 10 | $0 (2024) |
| Boston Scientific Corporation | $297.04 | 3 | $0 (2024) |
| ShockWave Medical, Inc | $292.35 | 8 | $0 (2024) |
| Philips Electronics North America Corporation | $289.72 | 4 | $0 (2019) |
| PFIZER INC. | $248.21 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,834 | 91 | Novartis Pharmaceuticals Corporation ($314.66) |
| 2023 | $1,802 | 81 | AstraZeneca Pharmaceuticals LP ($300.09) |
| 2022 | $1,079 | 30 | Medtronic, Inc. ($400.49) |
| 2021 | $15,182 | 13 | Medtronic, Inc. ($14,984) |
| 2020 | $91.28 | 4 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($77.49) |
| 2019 | $297.94 | 7 | Philips Electronics North America Corporation ($154.27) |
| 2018 | $475.81 | 11 | Edwards Lifesciences Corporation ($156.08) |
| 2017 | $479.85 | 5 | BOSTON SCIENTIFIC CORPORATION ($274.85) |
All Payment Transactions
242 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Cardiology | ||||||
| 12/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/10/2024 | W. L. Gore & Associates, Inc. | GORE EXCLUDER AAA Endoprosthesis (Device) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Devices | ||||||
| 11/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $4.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $36.94 | General |
| Category: Lithoplasty | ||||||
| 11/07/2024 | Medtronic, Inc. | ABRE (Device) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Stents | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $45.79 | General |
| Category: Stents | ||||||
| 11/01/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $19.77 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/31/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $36.50 | General |
| Category: Lithoplasty | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | WATERMARK MEDICAL, INC. | ARES 620 UNICORDER (Device) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: VENTILATORY EFFORT RECORDER | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $38.68 | General |
| Category: Lithoplasty | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/08/2024 | W. L. Gore & Associates, Inc. | GORE CARDIOFORM Septal Occluder (Device) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Devices | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 2,928 | 3,767 | $1.0M | $402,201 |
| 2022 | 7 | 220 | 287 | $49,420 | $20,105 |
| 2021 | 5 | 213 | 380 | $104,028 | $27,441 |
| 2020 | 5 | 215 | 383 | $103,594 | $27,724 |
Total Patients
3,576
Total Services
4,817
Medicare Billing
$477,470
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 423 | 779 | $93,480 | $50,700 | 54.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 397 | 424 | $106,050 | $45,809 | 43.2% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 33 | 33 | $92,400 | $45,613 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 251 | 414 | $76,640 | $44,457 | 58.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 118 | 123 | $67,650 | $20,694 | 30.6% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 33 | 33 | $52,800 | $20,646 | 39.1% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 27 | 27 | $43,200 | $20,180 | 46.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 74 | 74 | $54,400 | $15,937 | 29.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 35 | 35 | $35,000 | $13,561 | 38.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 185 | 188 | $44,330 | $10,414 | 23.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 64 | 65 | $23,290 | $9,330 | 40.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $21,320 | $9,072 | 42.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 92 | $15,010 | $9,068 | 60.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 52 | 208 | $16,640 | $8,811 | 52.9% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 28 | 28 | $26,600 | $8,372 | 31.5% |
| 92941 | Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | Facility | 2023 | 12 | 12 | $28,800 | $6,470 | 22.5% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 28 | 29 | $21,750 | $6,200 | 28.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 13 | 14 | $30,100 | $6,007 | 20.0% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 33 | 33 | $16,005 | $5,308 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 33 | $8,710 | $4,853 | 55.7% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 23 | 23 | $12,650 | $4,735 | 37.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 77 | 79 | $23,700 | $4,471 | 18.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 236 | 293 | $13,185 | $3,549 | 26.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 37 | 37 | $9,250 | $3,247 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 37 | 37 | $6,780 | $3,006 | 44.3% |
About Dr. Devinder Singh, M.D
Dr. Devinder Singh, M.D is a Cardiovascular Disease healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2014. The National Provider Identifier (NPI) number assigned to this provider is 1841604105.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devinder Singh, M.D has received a total of $21,241 in payments from pharmaceutical and medical device companies, with $1,834 received in 2024. These payments were reported across 242 transactions from 34 companies. The most common payment nature is "Grant" ($14,800).
As a Medicare-enrolled provider, Singh has provided services to 3,576 Medicare beneficiaries, totaling 4,817 services with total Medicare billing of $477,470. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Internal Medicine
- Location Camden, NJ
- Active Since 06/16/2014
- Last Updated 08/12/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841604105
Products in Payments
- LifeVest (Device) $729.81
- LEQVIO (Drug) $394.66
- FLOWTRIEVER CATHETER, S (Device) $307.10
- FARXIGA (Drug) $300.95
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $292.35
- GENERAL - THERAPIES (Device) $274.85
- Barostim Neo System (Device) $243.03
- JARDIANCE (Drug) $237.52
- COREVALVE EVOLUT R (Device) $231.98
- ELIQUIS (Drug) $196.14
- CoreValve Evolut (Device) $184.35
- ENTRESTO (Drug) $183.14
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $156.08
- BRILINTA (Drug) $154.94
- IGT Devices Und (Device) $154.27
- Image Guided Therapy Devices _ Coronary (Device) $135.45
- XARELTO (Drug) $129.32
- RESOLUTE ONYX (Device) $127.27
- XIFAXAN (Drug) $125.00
- Repatha (Biological) $114.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Camden
Dr. Perry Weinstock, M.d, M.D
Cardiovascular Disease — Payments: $257,830
Cardiovascular Disease $257,830
Mubashar Khan, M.d, M.D
Cardiovascular Disease — Payments: $33,373
Cardiovascular Disease $33,373
Zoltan Turi, Md, MD
Cardiovascular Disease — Payments: $28,055
Cardiovascular Disease $28,055
Dr. Brian Corbett, D.o, D.O
Cardiovascular Disease — Payments: $16,931
Cardiovascular Disease $16,931
Kathleen Heintz, Do, DO
Cardiovascular Disease — Payments: $10,143
Cardiovascular Disease $10,143
Dr. Matthew Ortman, M.d, M.D
Cardiovascular Disease — Payments: $9,897
Cardiovascular Disease $9,897